Date of Last Review 12/15/2011
SME: Director of Research
Investigational drugs include those substances in clinical stages of evaluation
that the Food and Drug Administration has not yet released for distribution.
The investigator must follow these guidelines before conducting research:
 | Submit the protocol to the following: |
 | Committee for Protection of the Human Subjects |
| Pharmacy and Therapeutic Committee of UTHCPC |
| UTHCPC Research Committee |
| Consult the Director of Pharmacy Services or designee |
The investigator must follow these guidelines after starting the research:
| Use the investigational drugs only in accordance with the procedure described in the protocol approved by CPHS |
| Supervise the usage of the investigational drugs |
| Not give an investigational drug for use to any of the following: |
| A patient not under his immediate supervision |
| Another physician not responsible to him/her |
| A patient not part of the research |
| A physician in another institution |
The master treatment plan will include the research protocol documentation.
Related Standard
The Joint Commission: Rights and Responsibilities of the Individual
If you have questions regarding the content of this site please contact the Policy and Procedure Committee. If you experience any technical problems please contact the MIS Department..
